LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

Search

Medpace Holdings Inc

Chiusa

SettoreSettore sanitario

490.59 -1.36

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

488.7

Massimo

495.52

Metriche Chiave

By Trading Economics

Entrata

-24M

90M

Vendite

45M

603M

P/E

Media del settore

36.505

35.664

EPS

3.67

Margine di Profitto

14.961

Dipendenti

6,000

EBITDA

-2.8M

118M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

-12.23% downside

Dividendi

By Dow Jones

Utili prossimi

20 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

4.9B

14B

Apertura precedente

491.95

Chiusura precedente

490.59

Notizie sul Sentiment di mercato

By Acuity

50%

50%

148 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

Medpace Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

12 set 2025, 22:41 UTC

I principali Market Mover

GlucoTrack Stock Falls on Plans to Sell $3 Million Note

12 set 2025, 16:04 UTC

I principali Market Mover

Upexi Shares Climb on Solana Gains

14 set 2025, 23:48 UTC

Discorsi di Mercato

Oil Futures Mixed Amid Divergent Signals -- Market Talk

14 set 2025, 23:41 UTC

Discorsi di Mercato

Gold Edges Lower on Likely Technical Correction -- Market Talk

14 set 2025, 23:38 UTC

Discorsi di Mercato

China's Economic Activity Data May Continue Reflecting Slowdown -- Market Talk

14 set 2025, 23:13 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

14 set 2025, 23:13 UTC

Discorsi di Mercato

Global Energy Roundup: Market Talk

14 set 2025, 23:13 UTC

Discorsi di Mercato

Infratil May Need to Be More Aggressive With Asset Sales -- Market Talk

14 set 2025, 23:13 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

14 set 2025, 23:04 UTC

Discorsi di Mercato

Aristocrat's Interactive Unit Appears in Safe Hands -- Market Talk

13 set 2025, 08:20 UTC

Discorsi di Mercato
Utili

Tech, Media & Telecom Roundup: Market Talk

12 set 2025, 20:50 UTC

Discorsi di Mercato
Utili

Tech, Media & Telecom Roundup: Market Talk

12 set 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

12 set 2025, 20:09 UTC

Utili

Correction to Opendoor Is Sliding. Don't Call It a Meme Stock, Says New Chairman. -- Barrons.com

12 set 2025, 19:23 UTC

Discorsi di Mercato

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

12 set 2025, 19:16 UTC

Discorsi di Mercato

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

12 set 2025, 19:03 UTC

Discorsi di Mercato

Natural Gas Futures Held Back By Plump Inventories -- Market Talk

12 set 2025, 18:59 UTC

Discorsi di Mercato

Dollar Pares Gains as Economy Keeps Showing Signs of Cooling -- Market Talk

12 set 2025, 18:38 UTC

Discorsi di Mercato
Utili

Adobe Seen Reaching Turning Point in AI Cycle -- Market Talk

12 set 2025, 18:33 UTC

Discorsi di Mercato

U.S. Oil Rig Count Rises By 2 to 416 -- Market Talk

12 set 2025, 18:22 UTC

Discorsi di Mercato

Canada's Divergence With US On Capex Spending is 'Appalling' -- Market Talk

12 set 2025, 16:56 UTC

Discorsi di Mercato

Renewable Fuels Association Calls for Nationwide E15 Following WASDE -- Market Talk

12 set 2025, 16:22 UTC

Utili

Adobe Earnings Were 'Solid.' Long-Term Growth Concerns Remain. -- Barrons.com

12 set 2025, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

12 set 2025, 16:19 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

12 set 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

12 set 2025, 16:11 UTC

Utili

Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. -- Barrons.com

12 set 2025, 15:37 UTC

Discorsi di Mercato

Gold Holds Near All-Time Highs Ahead of Fed Meeting Next Week -- Market Talk

12 set 2025, 15:22 UTC

Discorsi di Mercato

European Gas Lifted by Geopolitical Risks But Storage Levels Ease Supply Fears -- Market Talk

12 set 2025, 15:07 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

Confronto tra pari

Modifica del prezzo

Medpace Holdings Inc Previsione

Obiettivo di Prezzo

By TipRanks

-12.23% in calo

Previsioni per 12 mesi

Media 430.64 USD  -12.23%

Alto 531 USD

Basso 300 USD

Basato su 12 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Medpace Holdings Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

12 ratings

2

Acquista

8

Mantieni

2

Vendi

Punteggio Tecnico

By Trading Central

300 / 302.88Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Weak Bearish Evidence

Sentiment

By Acuity

148 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat